NURTuRE-CKD reaches half-way mark (August 2018)
We are delighted to report that we have reached the half-way mark of 1500 patients recruited to NURTuRE-CKD. This is a very significant milestone and reflects the effort and enthusiasm at all sites, with many people going “above and beyond” to overcome obstacles and help get us to this important point. There is still much more to do before we reach our final target of 3000 patients, but a moment to celebrate will create the positive energy to propel us forwards. Congratulations and thank you to everyone working on NURTuRE.
Fiona Robertson Maarten Taal
Project Manager Chief Investigator
Royal Derby Hospital leading the way on recruitment (July 2018)
The Royal Derby Hospital has reached their CKD patient recruitment target this month and as one of 14 sites taking part in NURTuRE, this takes the total number of patients already participating in the project to over 1,600.
Two posters presented at UK Kidney Week (Harrogate) June 2018
How taking part in research will help future kidney patients (March 2018)
Salford Royal NHS Foundation Trust focuses on NURTuRE ahead of World Kidney Day on 8th March 2018.
Professor Phil Kalra, Lead Investigator for NURTuRE at the hospital describes the study and two patients, David and Laura, share their stories and why they are taking part
Read more here
Thank you to David and Laura and Salford Royal NHS Foundation Trust for allowing us to share this news item
NURTuRE intersite newsletter. Issue 1 (December 2017)
NURTuRE features in Kidney Research UK’s Update magazine (November 2017)
NURTuRE features in Journal of Kidney Care (July 2017)
NURTuRE Launch News Release
Launch of unique kidney biobank
Weds 14 June 2017
Kidney Research UK, the UK charity dedicated to funding research into kidney disease, has launched the first kidney biobank covering England, Scotland and Wales. The biobank has been named NURTuRE (the National Unified Renal Translational Research Enterprise). Developed in the first instance to collect and store biological samples from 3,000 patients with chronic kidney disease (CKD) and at least 800 patients with nephrotic syndrome (NS), the biorepository will provide a strategic resource for fundamental and translational research. In addition to the samples of plasma, serum, urine, DNA and tissue that will be stored, the repository will also have the considerable advantage of containing associated linked clinical data, through the UK Renal Registry.